- Investigational, novel eye drop candidate was assigned PDUFA goal date of October 22, 2023 PONTE VEDRA, Fla., Feb. 21, 2023 /PRNewswire/ -- Orasis Pharmaceuticals, an emerging ophthalmic ...

Medically reviewed by Angela Ryan Lee, MD A CSF leak can cause symptoms such as headaches, nausea, and a runny nose. You can ...

Spectrum Pharmaceuticals Inc. celebrated a long-awaited win with the U.S. FDA’s approval late Sept. 9 of novel G-CSF drug eflapegrastim, cleared for use in chemotherapy-induced neutropenia nearly four ...

More than any other biofluid, the cerebrospinal fluid is in intimate contact with the brain. What can the thousands of proteins churning within this brain bath tell us about how Alzheimer’s develops, ...

An Ono Pharma drug for a type of tumor affecting tissues of the joints is now FDA approved, giving the Japanese company a product with dosing and safety advantages over the Daiichi Sankyo product that ...